Provided by Tiger Fintech (Singapore) Pte. Ltd.

JUNSHI BIO

20.900
-0.400-1.88%
Volume:6.48M
Turnover:135.46M
Market Cap:21.46B
PE:-14.69
High:21.650
Open:21.300
Low:20.300
Close:21.300
Loading ...

Shanghai Junshi Biosciences Raises HK$1.04 Billion Following Share Sale; Shares Gain 7%

MT Newswires Live
·
23 Jun

BUZZ-Shanghai Junshi Biosciences falls on discounted share sale

Reuters
·
13 Jun

Shanghai Junshi Biosciences - to Place 41 Mln Shares at HK$25.35 per H Share

THOMSON REUTERS
·
13 Jun

Junshi Biosciences' Unit Gets Nod to Trial Monkeypox Vaccine; Shares Up 5%

MT Newswires Live
·
12 Jun

Shanghai Junshi Biosciences - Unit Received Acceptance Notice Issued by National Medical Products Administration

THOMSON REUTERS
·
11 Jun

HK Movers | Biotech Stocks Jump With JW Therapeutics up 11%

Tiger Newspress
·
29 May

Shanghai Junshi Biosciences - Approval of Supplemental New Drug Application for Ongericimab Injection by Nmpa

THOMSON REUTERS
·
27 May

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
21 May

Junshi Biosciences Gets Registration Certificate in China for 12th Indication of Melanoma Drug

MT Newswires Live
·
28 Apr

Shanghai Junshi Biosciences - Approval of Supplemental New Drug Application for Toripalimab From Nmpa

THOMSON REUTERS
·
25 Apr

Press Release: Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

Dow Jones
·
29 Mar

Shanghai Junshi Biosciences Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.
·
29 Mar

Shanghai Junshi Biosciences 2024 Loss Shrinks 44%

MT Newswires Live
·
28 Mar

BRIEF-Shanghai Junshi Biosciences Posts FY Loss Attributable Of RMB1,282 Mln

Reuters
·
27 Mar

Shanghai Junshi Biosciences - as at 31 December 2024, Total Revenue RMB1,948 Mln

THOMSON REUTERS
·
27 Mar

Chinese Shares Rise Despite Dip in Industrial Profit; Zhejiang China Commodities City Jumps 7%

MT Newswires Live
·
27 Mar

BRIEF-Shanghai Junshi Biosciences Gets Approval By HSA For Marketing Of Toripalimab

Reuters
·
26 Mar

Shanghai Junshi Biosciences - Approval by Hsa for Marketing of Toripalimab

THOMSON REUTERS
·
26 Mar

Junshi Biosciences Gets Nod to Market Hepatocellular Carcinoma Drug

MT Newswires Live
·
24 Mar

BRIEF-Shanghai Junshi Biosciences Announces Approval Of Supplemental New Drug Application For Toripalimab

Reuters
·
21 Mar